1https://www.avient.com/sites/default/files/2020-09/stat-tech-tri-fold-processing-guide.pdf 2https://www.avient.com/sites/default/files/2020-12/therma-tech-processing-guide.pdf 1Gravi-Tech Processing Guide https://www.avient.com/sites/default/files/2020-10/2020-gravi-tech-processing-guide.pdf

uri=CELEX:32019L0904 - Achieving a specific rPET content in the bottles can, in some countries, lead to avoidance of taxes surcharges.

In order to have a masterbatch recognized by UL, the following conditions must be met: • the color concentrate producer must be recognized by UL • the polymer, generic or specific, must be recognized as well • the recognition of the material combination (base resin + color concentrate) must be listed in the QMSQ2 file of the concentrate producer • the specification limits set in the QMQS2 file must be respected if the UL94 recognition is to apply to the final plastic part Avient has a wide range of color and cost options available to provide maximum flexibility. For most updated information please refer to Avient UL recognized color concentrate file QMQS2 E73454.

Fiber Technology Barrier Technologies Avient Corporation 107 We are breaking ground on a new innovation center adjacent to our manufacturing facility in Pune • Focused on investments in both R&D resource additions and capital investments • Platform development in new disruptive markets to support core business and strategy ISHA Avient Manufacturing Site, Pune, India India Innovation Center Innovative Sustainable Holistic Accelerator (ISHA) Avient Corporation 108 2021E 2022E 2023E 2024E 2025E $1.1B $1.6B Growth Through Innovation Avient Corporation 109 Total CAI and SEMWorld-Class Vitality Index % of revenue from products launched last five years 12% 35% 2006 2021E Revenue from new products Investor Day 2021 Summary Jamie Beggs Avient Corporation 110 $442 $457 $580 2019PF 2020PF 2021E $1.74 $1.93 $3.00 2019PF 2020PF 2021E Full Year 2019 – 2021 Organic Growth (TOTAL COMPANY) Sales Adjusted EBITDA $3,981 $3,783 $4,750 2019PF 2020PF 2021E + 19% Adjusted EPS (1) Financial information is pro forma to include a full year of Clariant Color acquisition (1) (1) (in millions) (in millions) (1)(1) + 31% + 72% (1) (1) Avient Corporation 111 2021 Sales Growth Summary Key Growth Drivers Segments (1) Financial information is pro forma to include a full year of Clariant Color business acquisition Sales Growth Rate 2020 Proforma 3,783$ Sustainable Solutions 140 18% Healthcare 150 31% Composites 44 33% Growth in Asia / LATAM 103 21% Other 530 28% 2021 Estimated 4,750$ 26% (1) (1) Sales Growth Rate 2020 Proforma 3,783$ Color, Additives & Inks 330 16% Specialty Engineered Materials 195 28% Distribution 495 45% Corporate & Eliminations (53) 2021 Estimated 4,750$ 26% Avient Corporation 112 Year–to–date EBITDA Bridge 2020 September YTD $ 339 Demand 132 Adjusted EBITDA($ millions) (1) Financial information is pro forma to include a full year of Clariant Color business acquisition (1) CAI: Price / Mix 96 Inflation (74) SEM: Price / Mix 61 Inflation (45) Distribution: Price / Mix 204 Inflation (195) Net Price Benefit 47 Supply Chain Disruptions (38) COVID Response Applications (11) Synergies 34 Incentives, Travel, FX, Other (48) 2021 September YTD $ 455     • Demand driven by growth in sustainable solutions, healthcare and consumer applications • Price increases have more than covered raw material and freight inflation impacts of $300M year- to-date compared to 2020 • Synergy capture on pace to achieve $52M in annual savings in 2021 Avient Corporation 113 2006 2021E $1,110 $3,000 Return on Invested Capital Avient Corporation 114 Invested Capital 2006 Current 11% 8% Cost of Capital 2006 2021E 5% 12% ROIC (after-tax) ($ millions) 0.1 0.1 0.2 0.5 0.6 0.7 0.8 0.9 0.9 1.0 1.0 11 12 13 14 15 16 17 18 19 20 21 44% 98% YTD 5 - YR 10 - YR 0.16 0.20 0.26 0.34 0.42 0.50 0.58 0.72 0.79 0.81 0.85 0.95 11 12 13 14 15 16 17 18 19 20 21 22 2.1x Q4 NET LEVERAGE ~$1Bn REPURCHASED OVER LAST 10 YEARS ~$450MM PAID OVER LAST 11 YEARS Creating Value for Shareholders Avient Corporation 115 Share Performance Dividends Share Repurchases Deleveraging 3.5x 2.1x 2019PF 2021E Growing Dividend Cumulative Buybacks Net Leverage $B n $ p e r sh ar e Total Shareholder Return ~$4.3Bn MARKET CAP INCREASE OVER LAST 10 YEARS (1) Share performance includes reinvested dividends and is as of December 2, 2021 (2) Financial information is pro forma to include a full year of Clariant Color acquisition (1) (2) 528% Shaping a Sustainable Future… Avient Corporation 116 What We Shared Today SUSTAINABLE SOLUTIONS $340 $930 2016 2021E Brand Owner Commitment 3 2021E 2025E 10 – 50 Percent of recycled plastic used Avient Historic Growth Future Growth Assumptions 13% organic CAGR Net Sales ($ millions) Avient Corporation 117 8-12% CAGR What We Shared Today HEALTHCARE $225 $685 2010 2021E Megatrend Growth Rate 17,645 29,445 2021E 2025E Avient Historic Growth Future Growth Assumptions 9% organic CAGR Source: BCC Research, Nov. 2020 11% CAGR Market for Medical Plastics (millions of LBs) Figures above include relevant Sustainable Solutions sales Avient Corporation 118 Net Sales ($ millions) 8-10% CAGR What We Shared Today COMPOSITES $74 $260 2017 2021E 11% organic CAGR Figures above include relevant Sustainable Solutions sales Avient Corporation 119 Avient Historic Growth Future Growth Assumptions Net Sales ($ millions) 5G Capacity and Demand Source: Mobile Experts: 5G Millimeter Wave 2019: Radio Architecture and Outlook, March 2019 0 1 2 3 4 5 6 7 2019 2020 2021 2022 2023 2024 2025 2026 2027 D e ns e U rb an C ap ac ity ( G B /m o. ) Capacity below 6GHz 5G mm-wave capacity Demand (GB/mo) B B B B B B B B 10% CAGR Megatrend Growth Rate What We Shared Today ASIA AND LATIN AMERICA $210 $1,150 2010 2021E Weighted Avg. Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Reconciliation of EBITDA by Segment Year Ended December 31, 2019 Sales: Color, Additives and Inks $ 1,003.8 Specialty Engineered Materials 745.7 Distribution 1,192.2 Corporate and eliminations (79.0) Sales $ 2,862.7 Operating income: Color, Additives and Inks $ 147.4 Specialty Engineered Materials 83.7 Distribution 75.4 Corporate and eliminations (149.7) Operating income $ 156.8 Items below OI in Corporate: Other income, net $ 12.1 Depreciation & amortization: Color, Additives and Inks $ 42.7 Specialty Engineered Materials 29.5 Distribution 0.5 Corporate and eliminations 5.4 Depreciation & Amortization $ 78.1 EBITDA: Color, Additives and Inks $ 190.1 Specialty Engineered Materials 113.2 Distribution 75.9 Corporate and eliminations (132.2) EBITDA $ 247.0 EBITDA as a % of Sales: Color, Additives and Inks 18.9 % Specialty Engineered Materials 15.2 % Distribution 6.4 % 1 Reconciliation of Pro Forma EBITDA - Color, Additives and Inks Year Ended December 31, 2019 Sales: Color, Additives and Inks $ 1,003.8 Clariant Color pro forma adjustments(1) 1,118.6 Pro forma sales $ 2,122.4 Operating income: Color, Additives and Inks $ 147.4 Clariant Color pro forma adjustments(1) 72.9 Pro forma operating income $ 220.3 Depreciation & amortization: Color, Additives and Inks $ 42.7 Clariant Color pro forma adjustments(1) 60.3 Pro forma depreciation & amortization $ 103.0 EBITDA Color, Additives and Inks $ 190.1 Clariant Color pro forma adjustments(1) 133.2 Pro forma EBITDA $ 323.3 Pro forma EBITDA as a % of Sales 15.2 % (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 2009* 2010* 2011* 2012* 2013 2014 2015 2016** 2017 2018 2018*** 2019*** 2020 Net income from continuing operations attributable to Avient common shareholders $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 75.5 $ 152.7 Joint venture equity earnings, after tax (19.0) (14.7) (3.7) — — — — — — — — — — Special items, before tax(1) (48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 61.7 66.2 Special items, tax adjustments(1) (27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (5.9) (41.4) Adjusted net income from continuing operations attributable to Avient common shareholders $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 131.3 $ 177.5 Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 77.7 92.1 Adjusted EPS attributable to Avient common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 1.69 $ 1.93 * Historical results have been updated to reflect subsequent changes to accounting principle and discontinued operations, excluding any changes as a result of discontinued operations from the sale of the Designed Structures and Solutions segment (DSS) and the Performance Products and Solutions segment (PP&S). ** Pro Forma for sale of DSS. *** Pro Forma for sale of PP&S. *** Pro Forma for full year of the Clariant Color acquisition 2 Nine Months Ended September 30, Year Ended December 31, Reconciliation to Pro Forma Adjusted EBITDA 2020 2021 2020 2019 Net income from continuing operations – GAAP $ 59.1 $ 201.7 $ 133.8 $ 75.7 Income tax expense 22.5 51.8 5.2 33.7 Interest expense 55.3 57.8 74.6 59.5 Depreciation and amortization from continuing operations 77.3 107.7 115.1 78.1 EBITDA $ 214.2 $ 419.0 $ 328.7 $ 247.0 Special items, before tax 62.0 36.5 66.2 61.7 Interest expense included in special items (10.1) — (10.1) — Depreciation and amortization included in special items (2.5) (0.1) (3.2) — Adjusted EBITDA $ 263.6 $ 455.4 $ 381.6 $ 308.7 Clariant MB pro forma adjustments(1) 75.1 — 75.1 133.2 Pro forma adjusted EBITDA $ 338.7 $ 455.4 $ 456.7 $ 441.9 (1) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition Year Ended December 31, 2020 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5 Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0 Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6) Other income, net 24.3 (17.6) 6.7 — 6.7 Income taxes (5.2) (41.4) (46.6) (6.2) (52.8) Net income attributable to noncontrolling interests (1.8) — (1.8) — (1.8) Net income from continuing operations attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5 Weighted average diluted shares 90.6 Impact to diluted shares from January 2020 equity offering 1.5 Pro forma weighted average diluted shares 92.1 Pro forma adjusted EPS $ 1.93 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition 3 Year Ended December 31, 2019 Reconciliation of Pro Forma Adjusted Earnings per Share Avient Special Items Adjusted Avient Clariant MB Pro Forma Adjustments(1) Pro Forma Adjusted Avient Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3 Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4 Interest expense, net (59.5) — (59.5) (33.4) (92.9) Other income, net 12.1 (10.0) 2.1 — 2.1 Income taxes (33.7) (5.9) (39.6) (9.1) (48.7) Net income attributable to noncontrolling interests (0.2) — (0.2) — (0.2) Net income from continuing operations attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7 Weighted average diluted shares 77.7 Impact to diluted shares from January 2020 equity offering 15.3 Pro forma weighted average diluted shares 93.0 Pro forma adjusted EPS $ 1.74 (1) - Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects of the financing for the acquisition Return on Invested Capital Year Ended December 31, 2006 Short term debt $ 5.2 Current portion of long term debt 22.5 Long term debt 567.7 Shareholder's equity 574.5 Invested capital $ 1,169.9 Cash 66.2 Current invested capital (net) $ 1,103.7 Adjusted operating income 87.5 Current tax rate 0.33 Return on invested capital 5.3 % Year Ended December 31, Reconciliation to Enterprise Value / Adjusted EBITDA 2011 2016 Net income from continuing operations – GAAP $ 172.6 $ 165.0 Income tax expense 26.1 57.3 Interest expense 33.7 59.8 Depreciation and amortization from continuing operations 57.5 105.9 EBITDA $ 289.9 $ 388.0 Special items, before tax (46.7) 35.3 SunBelt equity income (5.7) — Depreciation and amortization included in special items — (5.4) Adjusted EBITDA $ 237.5 $ 417.9 Enterprise value(2) $ 1,542.0 $ 3,763.0 Enterprise value / adjusted EBITDA 6.5 9.0 (2) - Enterprise value is defined as market capitalization plus net debt 4 AVNT 2021 Investor Day adfa.pdf AVNT 2021 Investor Day.pdf AVNT 2021 Investor Day.pdf AVNT 2021 Investor Day - Final.pdf 2021 Investor Day Recs v3 12.2 (002).pdf

OUR CUSTOMER SUPPORT ACTIVITIES INCLUDE: • Food and Drug Administration (FDA) compliance support • Compliance with National Inventories • Biocompatibility compliance • REACH – European Legislation on Registration, Evaluation, Authorization and Restriction of Chemicals • Restriction on Hazardous Substances (RoHS) and Waste Electrical and Electronic Equipment (WEEE) electronics compliance • Data entry into the International Material Database System (IMDS) • Hazardous communication, including safety data sheets (SDS) and labeling GENERATING REGULATORY COMPLIANCE DOCUMENTATION INCLUDING: • California Proposition 65 • European Food Contact • Individual Customer Restricted Substance lists • Drug Master Files • Medical Application Files • Food and Drug Administration Certification • Potable Water Certification Contact us if you have questions or for specific information on your application’s regulatory compliance requirements.

In order to have a concentrate recognized by UL, the following conditions must be met: • the color concentrate producer must be recognized by UL • the polymer, generic or specific, must be recognized as well • the recognition of the material combination (base resin + color concentrate) must be listed in the QMSQ2 file of the concentrate producer • the specification limits set in the QMQS2 file must be respected if the UL 94 recognition is to apply to the final plastic part Avient has a wide range of color and cost options available to provide maximum flexibility. For most updated information please refer to Avient UL recognized color concentrate file QMQS2 E73454.

• Any action that may be taken at a meeting of the Committee may be taken by written consent so long as the written consent is unanimously approved and filed with the Corporate Secretary. 4 • The Company’s General Counsel and Corporate Secretary will be the management liaison to the Committee. • The Committee may appoint subcommittees from time to time as needed, and may delegate authority to such subcommittees or to officers of the Company, when appropriate, consistent with applicable laws, regulations, and listing standards. • The Corporate Secretary or his or her designee will be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least two times a year and at such other times as may be requested by its Chairman. • The Committee will regularly report the Committee’s activities and any recommendations to the Board in such manner and at such times as the Committee or the Board deems appropriate. • The Committee will annually review its charter and recommend any changes to the Board of Directors.

The action of a majority of those present at a meeting at which a quorum is present will be the act of the Committee. 4 Any action that may be taken at a meeting of the Committee may be taken by written consent so long as the written consent is unanimously approved and filed with the Corporate Secretary.

 Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:  The final amount of charges resulting from the planned North American asset realignment and the Company’s ability to realize anticipated savings and operational benefits from the asset realignment;  Our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies;  Our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive;  Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;  The financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability;  The speed and extent of an economic recovery, including the recovery of the housing market;  Our ability to achieve new business gains;  The effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks;  Changes in polymer consumption growth rates in the markets where we conduct business;  Changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online;  Fluctuations in raw material prices, quality and supply and in energy prices and supply;  Production outages or material costs associated with scheduled or unscheduled maintenance programs;  Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;  An inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, employee productivity goals, and an inability to raise or sustain prices for products or services;  An inability to raise or sustain prices for products or services;  An inability to maintain appropriate relations with unions and employees;  The inability to achieve expected results from our acquisition activities;  Our ability to continue to pay cash dividends;  The amount and timing of repurchases of our common shares, if any; and  Other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.  The above list of factors is not exhaustive.  We undertake no obligation to publicly update forward-looking statements, whether as a result of new information, future events or otherwise. The non-GAAP financial measures include: adjusted EPS, earnings before interest, tax, depreciation and amortization (EBITDA), adjusted EBITDA, net debt, Specialty platform operating income, Specialty platform gross margin percentage, adjusted operating income, return on invested capital, net debt/ EBITDA, and the exclusion of corporate charges in certain calculations.

TAXES Seller's invoices will include value added tax, and such value added tax shall be a separate line item on the invoice. Seller shall not be liable to Buyer for any other taxes or duties of any kind unless specifically and mutually agreed to between the parties. 9.